Patterns of venous collateral development after splenic vein occlusion associated with surgical and oncological outcomes after distal pancreatectomy
Executive Summary
Splenic vein occlusion (SpVO) is a significant clinical condition frequently encountered in patients undergoing distal pancreatectomy (DP), particularly those with pancreatic ductal adenocarcinoma (PDAC). This condition leads to left-sided portal hypertension (LSPH), resulting in splenomegaly, hypersplenism, and the development of complex collateral circulation.
Research indicates that SpVO is present in approximately 20.8% of DP cases. While it does not significantly alter overall survival (OS) when managed with comprehensive chemotherapy and surgical resection, it is associated with increased surgical complexity, higher rates of severe postoperative complications (Clavien–Dindo Grade ≥3), and specific patterns of tumor recurrence. Understanding the five distinct patterns of collateral venous flow—Left Gastroepiploic Vein (LGEV), Left Gastric Vein (LGV), Posterior Gastric Vein (PGV), Splenorenal (S-R), and Mixed types—is essential for preoperative planning to mitigate intraoperative risks.
Clinical and Pathological Characteristics of SpVO
The presence of SpVO fundamentally alters the physiological and anatomical landscape of the peripancreatic region. Analysis of patient data identifies several key clinicopathological differences between patients with patent splenic veins and those with SpVO.
Comparative Clinicopathological Parameters
Key Clinical Insights:
Hypersplenism: Patients with SpVO exhibit significantly lower platelet counts and higher splenic volumes, indicative of LSPH.
Surgical Complexity: SpVO cases are more likely to require multivisceral resection (23% vs. 4% in patent cases, p=0.005).
Postoperative Reversal: Platelet counts typically normalize or increase following the removal of the spleen, with SpVO patients showing significantly higher counts by postoperative day 7 compared to patent cases.
Surgical Outcomes and Complications
The presence of SpVO increases the difficulty of distal pancreatectomy. Although mortality rates remain at zero, the morbidity profile is markedly different for these patients.
Operative and Postoperative Metrics
Operation Time: SpVO procedures tend to be longer (279 vs. 250 minutes).
Blood Loss: There is a trend toward higher blood loss in SpVO cases (259g vs. 170g).
Severe Complications: There is a statistically significant increase in Clavien–Dindo Grade ≥3 complications in the SpVO group (23%) compared to the patent group (3%) (p=0.002).
Complication Profile: Specific Grade 3 complications noted in SpVO patients include intra-abdominal infection, postoperative pancreatic fistula (POPF), and pneumothorax.
Classification of Collateral Venous Flow Patterns
Identifying the specific route of collateral drainage is critical for preventing intraoperative congestion and bleeding. The research classifies collateral routes into five distinct patterns based on the main alternative outflow from the spleen.
Distribution and Description of Collateral Routes
Left Gastroepiploic Vein (LGEV) Type (46%): The most common pattern. Drainage occurs through the LGEV or middle colic vein via the arc of Barkow, flowing into the superior mesenteric vein (SMV). This is significantly associated with tumors located in the pancreatic body.
Left Gastric Vein (LGV) Type (19%): Collateral flow drains into the portal vein (PV) or the proximal splenic vein.
Posterior Gastric Vein (PGV) Type (19%): The PGV or short gastric veins serve as the main collateral route, draining into the splenic vein.
Splenorenal (S-R) Type (8%): Collateral flow drains into the systemic circulation via a splenorenal shunt.
Mixed Type (8%): Cases where multiple concurrent routes exist, making a single classification impossible.
Impact of Patterns on Operative Difficulty
Research suggests that LGEV and PGV patterns are associated with longer operative times and increased blood loss compared to other types, indicating that collateral circulation around the stomach and spleen significantly increases surgical difficulty.
Oncological Implications for PDAC Patients
For patients with pancreatic ductal adenocarcinoma (PDAC), SpVO serves as a marker for a more aggressive disease phenotype, characterized by larger tumors and higher rates of vascular involvement.
PDAC Oncological Parameters
Prognostic Observations:
Recurrence Patterns: Patients with SpVO have a higher incidence of peritoneal dissemination, whereas those with patent veins are more prone to liver metastases.
Survival Rates: Despite the more advanced disease characteristics in SpVO patients, overall survival and disease-free survival rates are comparable to patent cases. This is attributed to the more frequent use of neoadjuvant (70% vs. 25%) and adjuvant (87% vs. 69%) chemotherapy in the SpVO group.
Proposed Management Strategies
To enhance surgical safety, operative planning should prioritize the "preemptive occlusion of inflow"—blocking the splenic arterial blood flow before dissecting collateral vessels.
Surgical Recommendations by Collateral Pattern
LGEV Type: Minimize dissection of the gastrocolic ligament and occlude splenic artery (SpA) flow before manipulating the spleen.
LGV Type: Exercise caution if the LGV is anterior to the SpA. Consider a retroperitoneal approach or clamping the SpA at the suprapancreatic portion of the pancreatic tail.
PGV Type: Avoid dissection of the gastrosplenic ligament and splenic manipulation until the SpA is clamped.
Splenorenal Type: Avoid a retroperitoneal-first approach. If the SpA is buried in the pancreatic parenchyma, use a retroperitoneal approach or clamp the SpA at the suprapancreatic portion.
Conclusion
SpVO is a significant risk factor for perioperative complications in distal pancreatectomy due to the development of left-sided portal hypertension. While SpVO is associated with more aggressive PDAC phenotypes and higher rates of peritoneal recurrence, it is not an indicator of unresectability. A multimodal treatment strategy combining perioperative chemotherapy with a surgically precise, pattern-based approach to collateral circulation can achieve oncological outcomes comparable to patients with patent splenic veins.
